Mode
Text Size
Log in / Sign up

Metabolic profiles differ in memory T cells between TB progressors and non-progressors in Brazilian cohort

Metabolic profiles differ in memory T cells between TB progressors and non-progressors in Brazilian …
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider distinct T cell metabolic states in TB as preliminary, hypothesis-generating findings.

This proof-of-concept cohort study, conducted in Brazil (GSE112104), analyzed individuals with remote latent tuberculosis infection (LTBI), comparing Mtb-exposed progressors to non-progressors. The research focused on the immunometabolic profiles of distinct memory CD4+ T cell subsets (T-SCM/T-CM vs. T-TM/T-EM) following Mtb antigen stimulation, assessing outcomes like mitochondrial activity, oxidative metabolism, glycolytic reprogramming, and cytokine production.

The main findings revealed distinct metabolic signatures associated with disease containment versus progression. In non-progressors, T-SCM and T-CM subsets exhibited elevated mitochondrial activity and oxidative metabolism (fatty acid oxidation). Conversely, in progressors and active TB cases, T-TM and T-EM subsets showed glycolytic reprogramming, pentose phosphate pathway engagement, elevated exhaustion markers, and pro-inflammatory profiles. No quantitative effect sizes, p-values, or absolute numbers were reported for these observations.

Safety and tolerability data were not reported. The primary limitation is the study's designation as a proof-of-concept investigation, indicating its preliminary nature. The findings provide a basis for future longitudinal studies to examine dynamic metabolic and functional modulation in T cells from contained infection to disease progression. Clinical relevance is currently restrained to hypothesis generation for future research on immunometabolic pathways in TB.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Memory CD4+ T cells are central to long-term immunity in tuberculosis (TB), yet their functional roles that define their protective capacity remain unclear. Understanding the immune mechanisms that prevent clinical progression from latent TB infection (LTBI) to active TB disease is critical for the development of next-generation vaccines and biomarkers. We characterized the transcriptomic, metabolic, and functional programs of Mycobacterium tuberculosis (Mtb) antigen-stimulated peripheral CD4+ T stem cell (T-SCM), central (T-CM), transitional (T-TM), and effector (T-EM) memory subsets from individuals with remote LTBI. We utilized a multi-platform validation strategy that integrated RNA-sequencing data with protein-level metabolic profiling using “Met-Flow” cytometry and functional growth restriction assays to link memory CD4+ T cell differentiation states to immunometabolism and antimycobacterial function. Finally, we evaluated the immunometabolic profiles of memory CD4+ T cell subsets in an independent, longitudinal cohort of Mtb-exposed progressors and non-progressors from Brazil (GSE112104). We identified a differentiation gradient associated with distinct immunometabolic states. T-SCM and T-CM subsets exhibited elevated mitochondrial activity and oxidative metabolism (fatty acid oxidation), supporting their proliferative capacity. In contrast, T-TM and T-EM subsets underwent glycolytic reprogramming and engaged the pentose phosphate pathway, which fueled enhanced cytokine production and Mtb growth restriction. Importantly, we observed that non-progressors exhibit fatty acid oxidation-driven, stem/central memory-like signatures, while progressors and active TB cases display elevated exhaustion markers, glycolytic reprogramming and pro-inflammatory profiles aligned with disease progression. Collectively, findings from our proof-of-concept study suggest metabolic state as a key axis connecting Mtb antigen-induced memory T cell differentiation, restimulation-induced transcriptional programming, and durability of immune control. The findings provide the basis for future longitudinal studies to examine the dynamic metabolic and functional modulation in Mtb antigen-specific memory T cell subsets from contained infection to disease progression.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.